on DBV TECHNOLOGIES (EPA:DBV)
DBV Technologies Announces Details for Upcoming General Meeting
DBV Technologies, a late-stage biopharmaceutical company, is set to hold its Combined General Meeting on June 3, 2026. Scheduled for 10:00 a.m. CEST, the meeting will take place at the company's headquarters in Châtillon, France. Shareholders were informed about the meeting through a notice published on April 29, 2026, in the French Bulletin des Annonces Légales Obligatoires (BALO).
Key documents and preparatory materials for the meeting have been made accessible on the company's website. Shareholders have until May 29, 2026, to request these documents via email. The meeting will be streamed live online, with a recorded version available within seven business days post-meeting.
DBV Technologies focuses on developing treatments for food allergies utilizing its VIASKIN® patch technology, particularly targeting peanut allergies in young children.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all DBV TECHNOLOGIES news